General Information
Product name
Company
Subspeciality
Modality
Disease targeted
Main task
Not specified
Technical Specifications
Population
Patient population age
Not specified
Input
Input format
Output
Output format
Integration
Deployment
Trigger for analysis
Processing time
Regulatory Information
Pathway:
MDR
Class:
Class IIa
Pathway:
510(k) cleared
Class:
Class II
Other certifications
Not specified
Market Presence
On market since
AI Platforms
Resellers
Not specified
Countries present
Paying clinical customers
Research/test users
Pricing Information
Pricing model
Based on
Evidence & Research
Peer-Reviewed Papers
View
Reliable measurements of brain atrophy in individual patients with multiple sclerosis
View
Two Time Point MS Lesion Segmentation in Brain MRI: An Expectation-Maximization Framework
View
icobrain ms 5.1: Combining unsupervised and supervised approaches for improving the detection of multiple sclerosis lesions
Other Articles
View
A Novel Digital Care Management Platform to Monitor Clinical and Subclinical Disease Activity in Multiple Sclerosis
Source: vendor | First published: May 26, 2024 | Last updated: Jul 9, 2025